U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 11884

1.
Cancer-associated fibroblasts induce almonertinib resistance in non-small cell lung cancer
Guohao Wei, Yu Nie, Min Sun, Wenzheng Zhou, Huihui Zhao, Fangfang Chen, Chuandong Zhu
J Transl Med. 2025; 23: 42. Published online 2025 Jan 10. doi: 10.1186/s12967-024-06064-z
PMCID:
PMC11724582
AbstractArticlePDF–2.8M
2.
Abnormal expression of miR-668-3p in non-small cell lung cancer patients and its correlation with serum-related tumor markers
Wen Yang, Ling Liu, Jianliang Li, Yingchao Liu, Lin Rong, Junjie Ma, Rongchen Li, Qiuyue Zhang, Yugang Liu
J Cardiothorac Surg. 2025; 20: 58. Published online 2025 Jan 10. doi: 10.1186/s13019-024-03220-w
PMCID:
PMC11724551
AbstractArticlePDF–1.5M
3.
Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study
Helga H. Hektoen, Kaitlyn M. Tsuruda, Lars Fjellbirkeland, Yngvar Nilssen, Odd Terje Brustugun, Bettina K. Andreassen
Br J Cancer. 2025 Jan 31; 132(1): 93–102. Published online 2024 Nov 3. doi: 10.1038/s41416-024-02895-1
PMCID:
PMC11724112
AbstractArticlePDF–778K
4.
Impact of Triple Inhaler Therapy on COPD Patients with Non-Small Cell Lung Cancer After Radical Surgery: A Single-Centre Retrospective Analysis
Francesco Rocco Bertuccio, Vito D’Agnano, Simone Cordoni, Mitela Tafa, Cristina Novy, Nicola Baio, Klodjana Mucaj, Chandra Bortolotto, Giulio Melloni, Andrea Bianco, Angelo Guido Corsico, Fabio Perrotta, Giulia Maria Stella
J Clin Med. 2025 Jan; 14(1): 249. Published online 2025 Jan 3. doi: 10.3390/jcm14010249
PMCID:
PMC11722558
AbstractArticlePDF–490K
5.
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer
Subhamoy Chakraborty, Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar, Avisek Banerjee, Hilal Ozakinci, Yazhini Mahendravarman, Konrad Snioch, Elisa de Stanchina, Misty D. Shields, Lewis E. Tomalin, Deniz Demircioglu, Theresa A. Boyle, Anna Tocheva, Dan Hasson, Triparna Sen
Cell Rep Med. 2024 Dec 17; 5(12): 101852. Published online 2024 Dec 9. doi: 10.1016/j.xcrm.2024.101852
PMCID:
PMC11722101
AbstractArticlePDF–5.8M
6.
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
Jean-Philippe Guégan, Florent Peyraud, Bérengère Dadone-Montaudie, Diego Teyssonneau, Lola-Jade Palmieri, Emma Clot, Sophie Cousin, Guilhem Roubaud, Mathilde Cabart, Laura Leroy, Coriolan Lebreton, Christophe Rey, Oren Lara, Ophélie Odin, Maxime Brunet, Lucile Vanhersecke, Ezogelin Oflazoglu Gruyters, Ikbel Achour, Leila Belcaid, Sylvestre Le Moulec, Thomas Grellety, Alban Bessede, Antoine Italiano
Cell Rep Med. 2024 Dec 17; 5(12): 101831. Published online 2024 Nov 25. doi: 10.1016/j.xcrm.2024.101831
PMCID:
PMC11722093
AbstractArticlePDF–5.5M
7.
9,10-Dioxoanthracenyldithiocarbamates effectively inhibit the proliferation of non-small cell lung cancer by targeting multiple protein tyrosine kinases
Mateusz Olszewski, Maryna Stasevych, Viktor Zvarych, Natalia Maciejewska
J Enzyme Inhib Med Chem. 2024; 39(1): 2284113. Published online 2023 Dec 11. doi: 10.1080/14756366.2023.2284113
PMCID:
PMC11721965
AbstractArticlePDF–2.5M
8.
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions
Dong-Wan Kim, Alison M Schram, Antoine Hollebecque, Kazumi Nishino, Teresa Macarulla, Sun Young Rha, Michaël Duruisseaux, Stephen V Liu, Mohammed Najeeb Al Hallak, Kumiko Umemoto, Claas Wesseler, James M Cleary, Christoph Springfeld, Cindy Neuzillet, Andrew Joe, Shekeab Jauhari, Jim Ford, Koichi Goto
Future Oncol. 2024; 20(16): 1057–1067. Published online 2024 Feb 13. doi: 10.2217/fon-2023-0824
PMCID:
PMC11721935
AbstractArticlePDF–2.9M
9.
Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer
Lijie Sima, Zhongyuan Wang, Ling Yu, Youli Hou, Dongsheng Zhao, Bilan Luo, Weike Liao, Xinfu Liu
J Enzyme Inhib Med Chem. 2024; 39(1): 2286435. Published online 2023 Dec 11. doi: 10.1080/14756366.2023.2286435
PMCID:
PMC11721924
AbstractArticlePDF–2.1M
10.
Novel isobavachalcone derivatives induce apoptosis and necroptosis in human non-small cell lung cancer H1975 cells
Jie Chen, Long Zhao, Meng-Fan Xu, Di Huang, Xiao-Long Sun, Yu-Xin Zhang, Hong-Mei Li, Cheng-Zhu Wu
J Enzyme Inhib Med Chem. 2024; 39(1): 2292006. Published online 2023 Dec 12. doi: 10.1080/14756366.2023.2292006
PMCID:
PMC11721617
AbstractArticlePDF–2.0M
11.
Diagnostic role of circulating long non-coding RNA LINC00312 in patients with non-small cell lung cancer: a retrospective study
Ruoqian Zhang, Yan Jiang, Jing Gu, Xilin Zhang, Yanping Xie
BMC Cancer. 2025; 25: 47. Published online 2025 Jan 9. doi: 10.1186/s12885-024-13393-1
PMCID:
PMC11721336
AbstractArticlePDF–2.4M
12.
Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis
Mingfeng He, Xue Wu, Li Li, Guangming Yi, Yitian Wang, Hengqiu He, Ying Ye, Ruiqin Zhou, Zaicheng Xu, Zhenzhou Yang
Radiat Oncol. 2025; 20: 6. Published online 2025 Jan 9. doi: 10.1186/s13014-024-02578-4
PMCID:
PMC11721249
AbstractArticlePDF–1.8M
13.
Effect of perioperative methylprednisolone administration on postoperative pleural effusion in older patients with non-small cell lung cancer
Xinyu Hao, Yongxin Guo, Ziyao Xu, Yanping Song, Jingjing Liu, Likai Shi, Qiang Fu, Wenzhu Shi, Jiangbei Cao, Yanhong Liu, Li Tong, Weidong Mi
BMC Anesthesiol. 2025; 25: 20. Published online 2025 Jan 10. doi: 10.1186/s12871-025-02891-9
PMCID:
PMC11720918
AbstractArticlePDF–1.5M
14.
Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885
Simone E. Dekker, Lei Deng
Cancers (Basel) 2025 Jan; 17(1): 98. Published online 2024 Dec 31. doi: 10.3390/cancers17010098
Corrects:
Cancers (Basel). 2024 Nov; 16(22): 3885.
PMCID:
PMC11720402
CorrectionPDF–133K
15.
Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future Perspectives
Carol Zanchetta, Lorenzo De Marchi, Marianna Macerelli, Giacomo Pelizzari, Jacopo Costa, Giuseppe Aprile, Francesco Cortiula
Int J Mol Sci. 2025 Jan; 26(1): 221. Published online 2024 Dec 30. doi: 10.3390/ijms26010221
PMCID:
PMC11719753
AbstractArticlePDF–1.1M
16.
EML4-ALK: Update on ALK Inhibitors
Alessandra Bearz, Elisa Bertoli, Brigida Stanzione, Elisa De Carlo, Alessandro Del Conte, Martina Bortolot, Sara Torresan, Eleonora Berto, Valentina Da Ros, Giulia Maria Pelin, Kelly Fassetta, Silvia Rossetto, Michele Spina
Int J Mol Sci. 2025 Jan; 26(1): 308. Published online 2025 Jan 1. doi: 10.3390/ijms26010308
PMCID:
PMC11719670
AbstractArticlePDF–834K
17.
Machine Learning and Computed Tomography Radiomics to Predict Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Pilot Study
Ian Janzen, Cheryl Ho, Barbara Melosky, Qian Ye, Jessica Li, Gang Wang, Stephen Lam, Calum MacAulay, Ren Yuan
Cancers (Basel) 2025 Jan; 17(1): 58. Published online 2024 Dec 28. doi: 10.3390/cancers17010058
PMCID:
PMC11719007
AbstractArticlePDF–2.6M
18.
Integrated analysis of single-cell and bulk-RNA sequencing for the cellular senescence in prognosis of lung adenocarcinoma
Fengqiang Yu, Liangyu Zhang, Xun Zhang, Jianshen Zeng, Fancai Lai
Sci Rep. 2025; 15: 1442. Published online 2025 Jan 9. doi: 10.1038/s41598-025-85758-w
PMCID:
PMC11717922
AbstractArticlePDF–12M
19.
Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review)
Sirui Zhou, Jiazheng Sun, Weijian Zhu, Zhiying Yang, Ping Wang, Yulan Zeng
Oncol Rep. 2025 Feb; 53(2): 29. Published online 2024 Dec 30. doi: 10.3892/or.2024.8862
PMCID:
PMC11715622
AbstractArticlePDF–2.5M
20.
Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study
Tu Anh Do, Hoa Thi Thai Nguyen, Phuong Cam Pham, Khoi Tuan Nguyen, Thu Thi Anh Hoang, Anh Tuan Le, Hao Dinh Thy Vuong, Tam Dac Nhan Nguyen, Khiem Van Dang, Oanh Thi Nguyen, Luan Van Pham, Hai Minh Nguyen, Trang Thi Huyen Vo, Do Hung Kien, Thanh Ha Vu, Hang Thi Thuy Nguyen, Thai Van Pham, Huy Le Trinh, Gia Hoang Nguyen, Minh Cong Truong, Chau Tran Minh Pham, Phuong Thi Bich Nguyen
Asian Pac J Cancer Prev. 2024; 25(10): 3567–3576. doi: 10.31557/APJCP.2024.25.10.3567
PMCID:
PMC11711338
AbstractArticlePDF–672K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center